Children's cancers
Results
Phase 1
This trial looked at dalotuzumab alone and in combination with ridaforolimus. It was for children and young people whose cancer had continued to grow despite other treatment.
The trial was open for people to join between 2012 and 2013. The team published results in 2016. There is a link to more information in the ‘Summary of results’ section below.
Recruitment start: 1 March 2012
Recruitment end: 15 January 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Andrew Pearson
Experimental Cancer Medicine Centre (ECMC)
Merck Sharp & Dohme Ltd
NIHR Clinical Research Network: Cancer
Last reviewed: 6 May 2024
CRUK internal database number: 9152
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
